Screener
Eton Pharmaceuticals, Inc. ETON Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 5,709 | 7,463 |
| Total current assets | 53,245 | 60,581 |
| Property and equipment, net | 372 | 326 |
| Intangible assets, net | 43,738 | 30,878 |
| Operating lease right-of-use assets, net | 301 | 310 |
| Other long-term assets, net | 54 | 19 |
| Total assets | $97,710 | $92,114 |
| Liabilities and stockholders’ equity |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s intangibles (net)?
- Eton Pharmaceuticals, Inc. (ETON) reported intangibles (net) of $43.74M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Eton Pharmaceuticals, Inc.'s intangibles (net) increased by 29.1% year-over-year, from $33.88M to $43.74M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s intangibles (net)?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s intangibles (net) has grown at a 121.8% compound annual growth rate (CAGR), from $575K to $30.88M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Eton Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude